Yu Lou
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 62
- HIV/AIDS Research and Interventions 10
- Virology 29
- HIV Research and Treatment 29
- Co-authors
- Stephen C. Piscitelli (19 shared papers)Daniel S. Stein (14 shared papers)Sherene Min (14 shared papers)Julie Borland (14 shared papers)Ivy Song (12 shared papers)Brian M. Sadler (9 shared papers)Susan L. Ford (22 shared papers)Shuguang Chen (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (31 papers)British Journal of Clinical Pharmacology (6 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (6 papers)The Journal of Clinical Pharmacology (5 papers)AIDS (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Yu Lou
128 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 126
- Virology 999
- Infectious Diseases 1.8k
- Emergency Medicine 265
- Hepatology 168
- Pharmacology 157
Countries citing papers authored by Yu Lou
This map shows the geographic impact of Yu Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lou more than expected).
Fields of papers citing papers by Yu Lou
This network shows the impact of papers produced by Yu Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lou. The network helps show where Yu Lou may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 234 | |
| 2 | 2009 | 205 | |
| 3 | 2013 | 117 | |
| 4 | 2013 | 97 | |
| 5 | 2014 | 96 | |
| 6 | 2005 | 91 | |
| 7 | 2015 | 81 | |
| 8 | 2001 | 80 | |
| 9 | 2003 | 79 | |
| 10 | 2011 | 74 | |
| 11 | 2000 | 70 | |
| 12 | 2000 | 67 | |
| 13 | 2011 | 64 | |
| 14 | 2001 | 64 | |
| 15 | 1995 | 61 | |
| 16 | 2022 | 60 | |
| 17 | 2011 | 59 | |
| 18 | 2001 | 58 | |
| 19 | 1999 | 57 | |
| 20 | 2010 | 54 |
About Yu Lou
Yu Lou is a scholar working on Infectious Diseases, Virology, Epidemiology, Hepatology and Molecular Biology, having authored 132 papers that have together received 3.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (62 papers), HIV Research and Treatment (29 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Hepatitis C virus research (15 papers), HIV/AIDS Research and Interventions (10 papers), Pharmacological Effects and Toxicity Studies (10 papers), HIV-related health complications and treatments (9 papers) and Gout, Hyperuricemia, Uric Acid (7 papers). The work is most often cited by research in Virology (999 citations), Infectious Diseases (1.8k citations), Emergency Medicine (265 citations), Hepatology (168 citations) and Pharmacology (157 citations). Yu Lou has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Stephen C. Piscitelli, Daniel S. Stein, Sherene Min, Julie Borland, Ivy Song, Brian M. Sadler, Susan L. Ford, Shuguang Chen, Catherine Gillotin and William Spreen. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, The Journal of Clinical Pharmacology and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.